RxDoctor Payments Data

Kingsley Oladeji, MD

Adult Reconstructive Orthopaedic Surgery · Reno, NVNPI 1144727223

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.2%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 41.8% of the total.

$21,225in general payments, 2019–2025

Across 112 payments — averaging $189.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$9K
  • Evolution Surgical, Inc$7K
  • Smith+Nephew$4K
  • Zimmer Biomet$955
  • Convatec Inc.$100
  • Si-bone, Inc.$89
  • plus $169 from 2 others

What the payments were for

  • Travel & lodging$7,68236%
  • Food & beverage$6,18629%
  • Education$7,35735%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker69$8,878
Evolution Surgical, Inc8$7,417
Smith+Nephew21$3,617
Zimmer Biomet10$955
Convatec Inc.1$100
Si-bone, Inc.1$89
Medtronic1$85
Vertex1$84

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$65,185
Medicare patients
210
Services billed
796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl14$663
Oxycodone Hcl63$415
Meloxicam97$291
Ondansetron OdtOndansetron18$273
Doxycycline Hyclate14$225
Celecoxib13$209
Pantoprazole Sodium34$83
Tramadol Hcl15$45

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →